ArticleJournal of gambling studies2026
Long‑Term Gambling Disorder Care Trajectories and Associated Patient Characteristics and Quality of Care.
Article in Journal of gambling studies, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Given the limited evidence on the long‑term course of gambling disorder (GD), this study identified GD care trajectories, estimated GD duration, and examined their associations with patient and gambling characteristics and quality of care. A cohort of 2,154 patients with GD was examined using Quebec's administrative health records. We generated 13‑year GD care trajectories (2009-2022) using group‑based trajectory modeling. Multinomial logistic regression assessed the influence of sociodemographic, clinical, and gambling characteristics and quality‑of‑care indicators on trajectory membership. Four care trajectories were identified: Trajectory 1 (Transient GD, 34%), Trajectory 2 (Low‑intensity GD, 32%), Trajectory 3 (High initial, decreasing GD, 18%), and Trajectory 4 (Chronic GD, 16%). Two thirds of patients had GD records for an average of 1-2 years (Trajectories 1-2); GD persisted for 4 years in Trajectory 3 and 8 years in Trajectory 4. Compared with Trajectory 1, Trajectories 4 and 3 included patients more likely to be in their 50s and at higher risk of presenting severe clinical conditions, whereas Trajectory 2 patients were likelier to be younger, more socioeconomically deprived, and at greater risk of having a criminal history and co‑occurring alcohol‑ and drug‑related disorders. Patients in Trajectories 4 and 3 were more likely to receive GD‑specific treatments than those in Trajectories 1 and especially 2; however, Trajectories 2, 3, and 4 were at higher risk of showing lower treatment motivation. Trajectories 4 and 2 were also more likely to use non‑GD health services. Patients with long‑standing GD would benefit from enhanced follow‑up and crisis‑intervention strategies. Overall, improved detection across non‑GD care settings is needed to increase help‑seeking and support this vulnerable population.
Indexed as
Identifiers
42521894What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.